You have no items in your shopping cart.
Tybriva (Generic Imbruvica), manufactured by Emcure in India, is used to treat adult blood cancers such as lymphoma and leukaemia. This medication is also used to treat a condition of the immune system known as chronic graft versus host disease (cGVHD). Lymphoma is a type of cancer that affects immune system cells, which serve as the body's defence against infection. Leukemia, on the other hand, is a type of cancer that affects white blood cells. Lymphoma and leukaemia come in a variety of forms.
Tybriva should be used to treat the following conditions:
• Mantle cell lymphoma (MCL) • Chronic lymphocytic leukaemia (CLL) • Small lymphocytic lymphoma (SLL) • Waldenström's macroglobulinemia (WM) (MZL)
• Chronic Graft-versus-Host Disease (cGVHD) if at least one other systemic treatment was ineffective.
The active ingredient in Tybriva capsules, ibrutinib, works by inhibiting the activity of a specific protein known as Bruton's tyrosine kinase, or BTK. The protein Bruton's tyrosine kinase is found in your B cells. It sends "signals" that aid in the survival and proliferation of B cells. By inhibiting BTK, this generic medication aids in the killing and reduction of cancerous B-cells. This either prevents or slows the progression of cancer. In the case of cGVHD, BTK can cause an increase in the number of immune system cells. Furthermore, an overabundance of immune system cells can exacerbate your cGVHD. This medication prevents immune cells from reproducing, which alleviates your cGVHD symptoms.
You should take it as directed by your doctor or healthcare provider. Different Tybriva 140mg capsule dosages may be prescribed depending on the condition being treated. This medication is typically taken once daily, with or without food. There is no specific time of day when you should take this cancer medication. However, try to take the medication at roughly the same time every day. It should not be chewed, crushed, or split. Talk to your doctor or pharmacist about how to use Emcure ibrutinib safely while you're taking it. And, if you have difficulty swallowing capsules, speak with your healthcare provider about safe alternatives.
After the first dose, Tybriva 140 mg begins to inhibit the reproduction of cancer cells or overactive immune cells. You should continue to take it every day unless your condition worsens or you experience side effects from the medication. Never discontinue it without first consulting your doctor. Your doctor may order certain tests to see if Tybriva is working for you, depending on the type of cancer you have. Certain blood or imaging tests may be included in some cases.
• Decreased appetite
• Trouble breathing
• Pain in your muscles or joints
• Mild allergic reaction, such as skin rash; itchiness, and flushing (warmth and redness in your skin)
• Urinary tract infections
• Mouth sores (stomatitis)
This medication's safety in pregnant women has not been studied. This oral oncology drug, however, has been shown in animal studies to cause birth defects such as bone problems. However, keep in mind that the outcomes of animal studies do not always predict what will happen in humans. Because of the risks, it is not recommended that you use Tybriva 140 mg (Ibrutinib) if you are pregnant. Before taking generic Imbruvica, consult your doctor if you are pregnant or planning to become pregnant. They can advise you on how to manage your treatment.
It is unknown whether the medication passes into breast milk or whether it is safe for a breastfed child. If you are breastfeeding, you should consult your doctor before beginning to take Tybriva capsules. They can talk to you about safe and healthy ways to feed your child.
This medication comes with a number of warnings. Before taking it, discuss your medical history with your doctor. If you have certain medical conditions or other factors affecting your health, this medicine may not be right for you. These are some examples:
• Bleeding issues • Heart rhythm issues • Elevated cholesterol levels • High blood pressure • Diabetes • Liver issues • Allergic reaction • Kidney issues
Store Tybriva (Emcure Ibrutinib 140 mg) at room temperature 20°C to 25°C (68°F to 77°F). Excursions are permitted between 15°C and 30°C (59°F to 86°F).
Drugssquare is an authorized retailer, exporter, and supplier of Tybriva 140 mg Ibrutinib capsules in USA (United States of America), United Arab Emirates, UK (United Kingdom), Philippines, China, Hong Kong, Australia, Russia, Malaysia, Thailand, South Africa, Saudi Arabia, Nigeria, South Korea, Chile, Japan, Bangladesh, and other countries. We put patients first. If you want to purchase low-cost Emcure Tybriva 140mg (generic Imbruvica), place an order online with us today and we will deliver it directly to your door. Our specialty pharmacy strives to improve the lives of patients with blood cancer by providing generic blood cancer medications with huge discounts and special offers. Follow these few simple steps to order your medicines online without any hassle -
2. Select the quantity and add the product to the cart.
3. Upload prescription & complete the checkout process.
4. Confirm your order and pay your bill online.
5. Once payment is received, we will send your medication to the shipping address you provided.
In order to legally purchase this medicine from DrugsSquare, you’ll require a prescription from your Registered Medical Practitioner.
All content found on Drugssquare.com, including text, images, or other formats, is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always consult your doctor or other qualified health professionals if you have any questions regarding your health, medicine, or medical condition. This pharmacy is present to deliver, supply, export, or dispense prescription and OTC medicines online directly to consumers/patients.